Related references
Note: Only part of the references are listed.Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology
Lenneke Schrier et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
Beyond the Label: Steering the Focus Toward Safe and Effective Prescribing
Angela S. Czaja et al.
PEDIATRICS (2017)
Methodological and Ethical Issues in Pediatric Medication Safety Research
Delesha Carpenter et al.
PEDIATRICS (2017)
Off-label drug use in hospitalized children: a prospective observational study at Gondar University Referral Hospital, Northwestern Ethiopia
Yonas G. Tefera et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
Off-Label Prescribing: Justified or Not?
Xiulu Ruan et al.
AMERICAN JOURNAL OF MEDICAL QUALITY (2016)
Detection of Patients at High Risk of Medication Errors: Development and Validation of an Algorithm
Eva Aggerholm Saedder et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study
Alcidesio Sales de Souza et al.
BMC PEDIATRICS (2016)
Clinical research in neonates and infants: Challenges and perspectives
Raffaele Coppini et al.
PHARMACOLOGICAL RESEARCH (2016)
Off-label drug use in psychiatry: A retrospective audit in a tertiary care hospital
Kannan Sridharan et al.
ASIAN JOURNAL OF PSYCHIATRY (2016)
More than 5 years of European Paediatric Regulation: Statistics and industrial experience
Gesine Winzenburg
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation
L. Lindell-Osuagwu et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Off-Label Use of Drugs in Children
Daniel A. C. Frattarelli et al.
PEDIATRICS (2014)
Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA
Anna Paula de Sa Borges et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2013)
Ten Common Questions (and Their Answers) About Off-label Drug Use
Christopher M. Wittich et al.
MAYO CLINIC PROCEEDINGS (2012)
Pfizer settles largest ever fraud suit for off-label promotion
Mark Ratner
NATURE BIOTECHNOLOGY (2009)
Medication use in the neonatal intensive care unit: Current patterns and off-label use of parenteral medications
Praveen Kumar et al.
JOURNAL OF PEDIATRICS (2008)
Defining off-label and unlicensed use of medicines for children: Results of a Delphi survey
Antje Neubert et al.
PHARMACOLOGICAL RESEARCH (2008)
Voluntary anonymous reporting of medical errors for neonatal intensive care
G Suresh et al.
PEDIATRICS (2004)
Classification and heterogeneity of preterm birth
JM Moutquin
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2003)
Adverse drug reactions and off-label drug use in paediatric outpatients
B Horen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Unlicensed and off-label drug use in an Australian neonatal intensive care unit
CPF O'Donnell et al.
PEDIATRICS (2002)
A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital
GW 't Jong et al.
PEDIATRICS (2001)
Medication errors and adverse drug events in pediatric inpatients
R Kaushal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Survey of unlicensed and off label drug use in paediatric wards in European countries
S Conroy et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
